Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIMK1 | P53667 | 4/20 | 0.40 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.38 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | IKBKB | O14920 | 1/20 | 0.33 |
| ▸ | CHUK | O15111 | 1/20 | 0.33 |
| ▸ | CDC7 | O00311 | 1/20 | 0.33 |
| ▸ | CLK1 | P49759 | 1/20 | 0.33 |
| ▸ | DBF4 | Q9UBU7 | 1/20 | 0.33 |
| ▸ | RIPK2 | O43353 | 1/20 | 0.32 |
| ▸ | EGFR | P00533 | 1/20 | 0.32 |
| ▸ | KDR | P35968 | 1/20 | 0.32 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26535943 | 0.99 | LIMK1 (0.38) | LIMK1ROCK1PIM3RAB9AIKBKB | |
| SCHEMBL14752007 | 0.94 | LIMK1 (0.38) | LIMK1ROCK1PIM3ALDH1A1RAB9A | |
| SCHEMBL15836077 | 0.91 | LIMK1 (0.38) | LIMK1ROCK1PIM3ALDH1A1LMNA | |
| SCHEMBL17701423 | 0.87 | LIMK1 (0.40) | LIMK1ROCK1PIM3ALDH1A1LMNA | |
| SCHEMBL18252332 | 0.86 | MEN1 (0.36) | LIMK1ROCK1PIM3LMNARAB9A | |
| SCHEMBL25714496 | 0.83 | ALDH1A1 (0.37) | LIMK1ROCK1PIM3ALDH1A1CLK1 | |
| SCHEMBL25713449 | 0.83 | ALDH1A1 (0.35) | LIMK1ROCK1PIM3ALDH1A1LMNA | |
| SCHEMBL18252256 | 0.83 | MEN1 (0.38) | LIMK1ROCK1PIM3LMNARAB9A | |
| SCHEMBL22373660 | 0.83 | MAP4K4 (0.43) | ROCK1ALDH1A1 | |
| SCHEMBL18252330 | 0.83 | LIMK1 (0.34) | LIMK1ROCK1PIM3CDC7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230322691-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT | CANON KABUSHIKI KAISHA (JP) | 2023-10-12 | — | — | US | disclosed |
| US-20230322691-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT | CANON KABUSHIKI KAISHA (JP) | 2023-10-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230322691-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT | CCNT1, CCNE2, SCO2 | LIMK1 111/4885ROCK1 4515/4885PIM3 3398/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.